Why Catching Lymphoma Early Matters
Lymphoma is the most common haematopoietic (blood / immune system) cancer in dogs, accounting for about 7-24% of all canine neoplasia (Vail 2007, Withrow & MacEwen’s Small Animal Clinical Oncology). The classic presentation is a middle-aged-to-older dog with generalised lymphadenopathy — multiple peripheral lymph nodes enlarged simultaneously, painlessly, with the dog often surprisingly well-appearing.
Caught early, treated promptly, canine lymphoma has substantial treatment options — median survival on full CHOP chemotherapy is 12-14 months for B-cell lymphoma, vs 4-6 weeks untreated. Many dogs experience excellent quality of life during treatment, and a meaningful minority achieve long-term remission.
This calculator scores pre-test probability from owner-observable signs to indicate when lymph node aspirate cytology (the definitive diagnostic step) is warranted.
The Classic Presentation
Multicentric lymphoma (about 80-85% of canine lymphoma) presents as:
- Generalised peripheral lymphadenopathy — multiple nodes enlarged at once
- Painless — the dog doesn’t react to palpation
- Rubbery / firm texture
- No skin discolouration over the node
- Dog often surprisingly well at first — normal appetite, energy, behaviour
- Middle-aged to older — typical onset 6-12 years
The five peripheral lymph node groups an owner or vet can palpate:
| Lymph node | Location |
|---|---|
| Submandibular | Under the jaw, behind the angle of the jaw |
| Prescapular | In front of the shoulder blade |
| Axillary | In the armpit |
| Inguinal | In the groin |
| Popliteal | Behind the knee, on the inside aspect of the hock |
Normal lymph nodes are usually too small to feel in healthy dogs of medium size or larger. Easily-palpable, firm, multiple nodes enlarged simultaneously in an older dog is suspicious for lymphoma until proven otherwise.
The Less Common Forms
| Form | Frequency | Presentation |
|---|---|---|
| Multicentric | 80-85% | Generalised peripheral lymphadenopathy |
| Alimentary (GI) | 5-7% | Weight loss, vomiting, diarrhoea, GI mass on imaging |
| Mediastinal | 3-5% | Chest mass, pleural effusion, breathing difficulty |
| Cutaneous | 3-8% | Skin nodules, ulcers, depigmentation |
| Extranodal | rare | Ocular, CNS, renal, hepatic forms |
Hypercalcaemia of Malignancy
A critical secondary feature. 10-40% of canine lymphoma cases have elevated ionised calcium (Bergman 2007) — more common with T-cell phenotype. Hypercalcaemia presents as:
- PU/PD (polyuria / polydipsia)
- Vomiting
- Lethargy / weakness
- Acute kidney injury in severe cases
Measure ionised calcium specifically (not just total calcium — total can be normal while ionised is elevated, especially in low-albumin states). Hypercalcaemia is treated with IV fluids, sometimes bisphosphonates, while definitive lymphoma treatment is started.
PU/PD with suspected lymphoma should always prompt an ionised calcium measurement.
Breed Predispositions
The breeds most over-represented in published canine lymphoma populations:
- Boxer — notably elevated, with T-cell phenotype more common in Boxers than in other breeds. Median onset slightly younger (~6-8 years).
- Golden Retriever — North American Goldens have approximately 40-60% lifetime cancer incidence, with lymphoma and haemangiosarcoma the leading forms. The Morris Animal Foundation Golden Retriever Lifetime Study has been documenting this for over a decade.
- Bullmastiff
- Scottish Terrier
- Airedale Terrier
- Bernese Mountain Dog
- Saint Bernard
- Basset Hound
- Bulldog / English Bulldog
- Rottweiler
For at-risk breeds, routine peripheral lymph node palpation by owners is sensible — once a month is reasonable, takes 30 seconds, and catches the typical presentation early.
Diagnostic Workup
Step 1: Fine-Needle Aspirate Cytology
The definitive diagnostic test for multicentric lymphoma. Cheap, quick (often same-day result), no anaesthesia required:
- Largest enlarged lymph node aspirated with a fine needle
- Smears stained and examined microscopically
- 80-90% diagnostic for multicentric lymphoma
- Sometimes histopathology is needed if cytology is equivocal
Step 2: Staging
Once lymphoma is confirmed, WHO staging guides treatment and prognosis:
| Stage | Definition |
|---|---|
| I | Single lymph node involvement |
| II | Regional (multiple nodes one side of diaphragm) |
| III | Generalised peripheral lymphadenopathy |
| IV | Liver and/or spleen involvement |
| V | Bone marrow or other organ involvement |
Substage A (no systemic signs) vs B (systemic signs — weight loss, lethargy, etc.). Stage IIIa-IVa with B-cell phenotype has the best prognosis with treatment.
Step 3: Phenotype + Prognostic Tests
- Flow cytometry — B-cell vs T-cell, additional prognostic markers
- PCR for antigen receptor rearrangement (PARR) — confirms clonality, distinguishes lymphoma from reactive lymphadenopathy
- Bone marrow aspirate — if cytopenias or stage V suspected
- Thoracic radiographs + abdominal ultrasound — full staging
- Complete blood count, biochemistry, ionised calcium, urinalysis — baseline + hypercalcaemia screen
Treatment Options
The decision varies by owner priorities, finances, dog tolerance, and disease stage.
CHOP Chemotherapy (Gold Standard)
- 19-25 week multi-drug protocol: Cyclophosphamide, Doxorubicin (Hydroxydaunorubicin), Vincristine (Oncovin), Prednisolone
- Median first remission: 8-9 months
- Overall median survival: 12-14 months for B-cell, 5-6 months for T-cell
- About 20-25% of B-cell cases achieve long-term remission (>2 years)
- Cost: GBP 4,000-8,000 / USD 5,000-10,000 in specialist oncology
- Remarkably well-tolerated by most dogs — most maintain normal energy, appetite and behaviour throughout
COP Chemotherapy (Simpler)
- 3-drug oral protocol (cyclophosphamide, vincristine, prednisolone)
- Cheaper and lower-intensity
- Median 6-7 months
- Suitable when owner cannot afford CHOP or dog cannot tolerate doxorubicin
Single-Agent Doxorubicin
- 5 doses over 15 weeks
- Median 6-8 months
- Lower cost, fewer visits than CHOP
Palliative Prednisolone Alone
- Inexpensive (oral steroid)
- Median 6-8 weeks but improves quality of life until disease progresses
- Reasonable choice when chemotherapy is not pursued
Untreated
- Median survival 4-6 weeks from diagnosis
- Some hospice supportive care still appropriate (anti-emetics, appetite stimulants, pain management)
Chemotherapy In Dogs Is Better-Tolerated Than People Expect
The human-medicine stereotype of chemotherapy — severe nausea, hair loss, debilitation — does not apply to canine chemotherapy. Veterinary oncology uses sub-maximum-tolerated-dose (sub-MTD) intensity:
- Hair loss is rare in most breeds (continuous-coat breeds — Poodles, Wheatens, Old English Sheepdogs — lose more)
- Vomiting in 15-20% of treatments, manageable with anti-emetics
- Most dogs maintain normal appetite, energy, behaviour
- Severe complications (severe neutropenia with sepsis) in 3-5%, manageable with hospitalisation
- Quality of life during treatment is excellent for the great majority of dogs
This is a frequent surprise to owners considering chemo — the prospect of treating cancer in a dog is much less burdensome than the prospect of treating cancer in a human.
Differentials For Lymphadenopathy
Not all enlarged lymph nodes are lymphoma. The differentials:
Reactive Lymphadenopathy
- Local infection in the area drained by the node — skin, dental, ear, foot
- Skin disease — atopic dermatitis with secondary infection
- Ectoparasites — flea or tick infestation
- Usually involves only the regional node, not generalised
Infectious Disease
- Tick-borne diseases — ehrlichia, anaplasma, Lyme disease in endemic areas
- Leishmaniasis (Mediterranean / imported dogs)
- Brucellosis (intact breeding dogs)
- Blastomycosis, histoplasmosis (US endemic areas)
Immune-Mediated Disease
- Systemic lupus erythematosus
- Immune-mediated polyarthritis
Other Neoplasia
- Metastatic cancer from another primary
- Mast cell tumour spreading to nodes
- Leukaemia
Generalised painless rubbery lymphadenopathy in an older dog is most likely lymphoma, but cytology confirms.
Honest Caveats
- Pre-test probability is not diagnosis — cytology is the definitive next step.
- Many dogs with enlarged lymph nodes do not have lymphoma — reactive lymphadenopathy is common in younger dogs with infection or skin disease.
- A normal-feeling palpation does not rule out lymphoma — internal forms (alimentary, mediastinal, extranodal) can present without peripheral lymph node involvement.
- Owner palpation is approximate — vets find more nodes than owners.
- This calculator gives a screening probability; the cytology and staging give the actual answer.
Conclusion
Canine lymphoma is the most common haematopoietic cancer in dogs, with a classic presentation that owners can often catch — multiple peripheral lymph nodes enlarged simultaneously in a middle-aged-to-older dog who otherwise seems well. Lymph node aspirate cytology is the definitive diagnostic step — cheap, quick, no anaesthesia, usually diagnostic within 24-48 hours. CHOP chemotherapy is the standard treatment with median survival 12-14 months and excellent quality of life during treatment for most dogs. For at-risk breeds (Boxer, Golden Retriever, Bullmastiff, Bernese, Bulldog, Scottish Terrier), monthly owner palpation of peripheral lymph nodes catches the typical presentation early when treatment options are most favourable.
Frequently Asked Questions
What are the early signs of lymphoma in dogs?
The classic early presentation: GENERALISED PERIPHERAL LYMPHADENOPATHY – multiple peripheral lymph nodes enlarged simultaneously (submandibular under the jaw, prescapular in front of the shoulder, popliteal behind the knee), often painless and firm/rubbery, in a middle-aged-to-older dog who otherwise seems well. About 80% of canine lymphoma is multicentric. Some dogs present with systemic signs first – weight loss, lethargy, PU/PD (suggests hypercalcaemia), reduced appetite. Fine-needle aspirate cytology is the diagnostic step.
How is dog lymphoma diagnosed?
Fine-needle aspirate cytology of the largest enlarged lymph node is the definitive diagnostic test – cheap, quick (often same-day result), no anaesthesia required, ~80-90% diagnostic. After confirmation, full staging includes WHO stage I-V, B-cell vs T-cell phenotype (flow cytometry), thoracic radiographs, abdominal ultrasound, ionised calcium (10-40% have hypercalcaemia of malignancy), and sometimes bone marrow aspirate. PARR (PCR for antigen receptor rearrangement) confirms clonality in equivocal cases.
How long do dogs live with lymphoma?
Depends entirely on treatment choice. UNTREATED: median 4-6 weeks from diagnosis. PALLIATIVE PREDNISOLONE alone: median 6-8 weeks, inexpensive, improves quality of life until progression. SINGLE-AGENT DOXORUBICIN: median 6-8 months. COP (3-drug oral): median 6-7 months. CHOP chemotherapy (gold standard, 19-25 week multi-drug protocol): median first remission 8-9 months, overall median survival 12-14 months for B-cell lymphoma, 5-6 months for T-cell. About 20-25% of B-cell cases achieve long-term remission >2 years.
Is chemotherapy hard on dogs?
Much less than the human-medicine stereotype suggests. Veterinary oncology uses sub-maximum-tolerated-dose (sub-MTD) chemotherapy intensity. Hair loss is rare in most breeds (continuous-coat breeds like Poodles lose more). Vomiting in 15-20% of treatments, manageable with anti-emetics. Most dogs maintain normal energy, appetite, behaviour throughout. Severe complications (severe neutropenia with sepsis) in 3-5%, manageable with hospitalisation. Quality of life during canine chemo is excellent for the great majority.
Which dog breeds are most likely to get lymphoma?
Most over-represented in published canine lymphoma populations: Boxer (T-cell phenotype more common; median onset slightly younger 6-8 years), Golden Retriever (40-60% lifetime cancer incidence in some North American lines per the Morris Animal Foundation Golden Retriever Lifetime Study), Bullmastiff, Scottish Terrier, Airedale Terrier, Bernese Mountain Dog, Saint Bernard, Basset Hound, Bulldog/English Bulldog, Rottweiler. For these breeds, monthly owner palpation of peripheral lymph nodes is sensible.
Does my dog’s enlarged lymph nodes definitely mean cancer?
No – many other conditions cause lymphadenopathy. Reactive lymphadenopathy from local infection, skin disease, ectoparasites, dental disease usually involves only the REGIONAL node (one or two, not generalised). Tick-borne diseases (ehrlichia, anaplasma), leishmaniasis, brucellosis, fungal infections can cause generalised lymphadenopathy. Immune-mediated diseases (lupus, immune-mediated polyarthritis), other cancers (mast cell tumour, leukaemia), and metastatic disease from another primary are also possible. Cytology distinguishes them – usually within 24-48 hours of vet visit.
Related PuppaDogs Calculators
Continue building your dog’s personalised care plan with these related PuppaDogs calculators:
- Dog Pregnancy / Whelping Due-Date Calculator
- Puppy Weight Predictor (Adult Weight Calculator)
- Heatstroke Risk Calculator for Dogs
- Bloat (GDV) Risk Calculator for Dogs
- Dog Life Expectancy Calculator (Breed, Body Condition, Lifestyle)
- Spay/Neuter Timing Calculator for Dogs (Breed-Specific)
References & Further Reading
The dosing ranges and safety information on this page are drawn from the following veterinary references. Always defer to your own veterinarian and the manufacturer’s label for your specific product.
- Vail DM, Pinkerton ME, Young KM. Hematopoietic tumors. In Withrow & MacEwen’s Small Animal Clinical Oncology, 6th ed.
- Vail DM, Thamm DH, Liptak JM. Withrow and MacEwen’s Small Animal Clinical Oncology, 6th ed. Elsevier, 2019 – canine lymphoma chapters.
- Bergman PJ. Paraneoplastic hypercalcemia. Topics in Companion Animal Medicine, 2012.
- Morris Animal Foundation. Golden Retriever Lifetime Study – canine cancer epidemiology.
- Burton JH et al. Comparative evaluation of CHOP-based protocols for canine lymphoma. Journal of Veterinary Internal Medicine.
- ACVIM oncology consensus statements on canine lymphoma.
- PuppaDogs. Quality of Life Calculator and Water Intake & Polydipsia Calculator. puppadogs.com.
